Amgen releases 4th quarter earnings

You are here: Home > Biotech > Current Article

By Staff Report / Thursday, January 30th, 2020 / Comments Off on Amgen releases 4th quarter earnings

Amgen shares took a hit Jan. 30, as the company reported declines in sales and its bottom line and delivered a muted outlook for 2020. The Thousand Oaks-based biotech giant cited encroachment from biosimilars and generics as the reason behind a 1 percent dip in sales for the fourth quarter to $6.2 billion. Overall in…

This article is only available to Business Times subscribers

Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
Check the STATUS of your Subscription Account.